Lars B. Abrahmsen serves as Executive at Aprea Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Lars B. Abrahmsen has executed 6 insider transactions totaling $368.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 10, 2022 involved receiving (via award) 24,700 shares valued at $0.
Lars B. Abrahmsen currently holds 43,700 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lars B. Abrahmsen has been a net seller of APRE stock. They have purchased $0 and sold $368.8K worth of shares.
Lars B. Abrahmsen's most recent insider trade was on Mar 10, 2022, when they sold 24,700 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.92 |
| Discretionary |
| Oct 1, 2021 | APRE | $244.5K | Sale | 50,000 | $4.89 | Discretionary |
| Sep 20, 2021 | APRE | $23.0K | Option Exercise | 25,000 | $0.92 | Discretionary |
| Sep 20, 2021 | APRE | $124.3K | Sale | 25,000 | $4.97 | Discretionary |
| Feb 25, 2021 | APRE | $0 | Award | 19,000 | $N/A | Discretionary |